Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
BusinessBank’s collapse underlines role of U.S. money in global tech financing Source link
The chief executive of the biotechnology industry’s top lobbying group in Washington is on leave amid dissent within the organization...
Bristol-Myers Squibb Co. said it will acquire biotechnology company Turning Point Therapeutics Inc. TPTX 116.76% for $4.1 billion, an effort...
Biotech companies are having one of their worst stock-market runs in years, as rising interest rates, scientific setbacks and a...